Trial Profile
Clinical Trials Insight: 700028769
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary) ; Irbesartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 26 Nov 2007 New trial record.